Biblio
Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapy. Ann Hematol. 2022.
Immunosuppressive M2 TAMs represent a promising target population to enhance phagocytosis of ovarian cancer cells . Front Immunol. 2023;14:1250258.